Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease in Adults

Nonalcoholic fatty liver disease (NAFLD) is characterized by the accumulation of triglycerides in hepatocytes in the absence of excessive alcohol intake, ranging in severity from simple steatosis to nonalcoholic steatohepatitis (NASH). Nonalcoholic steatohepatitis can ultimately progress to cirrhosi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmacotherapy 2013-02, Vol.33 (2), p.223-242
Hauptverfasser:	Malinowski, Scott S., Byrd, Jennifer S., Bell, Allison M., Wofford, Marion R., Riche, Daniel M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Animals antioxidants Biological and medical sciences Disease Progression fatty liver Fatty Liver - drug therapy Fatty Liver - epidemiology Fatty Liver - pathology Gastroenterology. Liver. Pancreas. Abdomen Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Liver cirrhosis Liver diseases Liver. Biliary tract. Portal circulation. Exocrine pancreas Medical sciences Metformin - therapeutic use Mortality NAFLD NASH Non-alcoholic Fatty Liver Disease nonalcoholic fatty liver disease nonalcoholic steatohepatitis Other diseases. Semiology Pharmaceutical Preparations - administration & dosage Pharmacology. Drug treatments pioglitazone statin Thiazolidinediones - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!